Clinical Trial

A Study of Hospital-at-Home for People Receiving Tarlatamab

Name: A Study of Hospital-at-Home for People Receiving Tarlatamab — clinical trial record (NCT06957314)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to find out whether a Hospital-at-Home (HaH) program is a more efficient way to monitor people's health after receiving tarlatamab than monitoring in the hospital (inpatient).

Protocol Amendment History 7 amendments

This ClinicalTrials.gov record has been amended 7 times since 2025-04-25; most recent amendment 2026-06-11.

Trial Details

NCT Number	NCT06957314
Lead Sponsor	Memorial Sloan Kettering Cancer Center
Conditions	Small-cell Lung Cancer, Small Cell Lung Carcinoma
Enrollment	70 participants
Start Date	2025-04-23
Primary Completion	2028-04-23 (estimated)
Study Completion	2028-04-23 (estimated)
Updated on ClinicalTrials.gov	2026-06-12